Literature DB >> 1201207

Coagulation changes during the steady state in homozygous sickle-cell disease in Jamaica.

J Leslie, D Langler, G R Serjeant, B E Serjeant, P Desai, Y B Gordon.   

Abstract

Coagulation studies were carried out in 117 Jamaicans with homozygous sickle-cell disease in the steady state, and 40 local controls. The patients had significantly higher factor-VIII levels, higher platelet counts, lower factor-V and plasminogen levels, shorter thrombin times and higher serum fibrinogen degradation products (FDP) than the control group. The low factor-V and plasminogen levels, and high FDP levels, might be explained by activation of the coagulation system and continuous clot lysis even in the absence of painful crisis. The high factor-VIII levels and short thrombin times found in these patients could not be explained.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1201207     DOI: 10.1111/j.1365-2141.1975.tb00530.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  10 in total

Review 1.  Redox-dependent impairment of vascular function in sickle cell disease.

Authors:  Mutay Aslan; Bruce A Freeman
Journal:  Free Radic Biol Med       Date:  2007-08-31       Impact factor: 7.376

2.  Hyperfibrinogenaemia and hyperviscosity in sickle-cell crisis.

Authors:  S G Richardson; G R Breeze; J Stuart
Journal:  J Clin Pathol       Date:  1976-10       Impact factor: 3.411

3.  Coagulation changes in homozygous sickle cell disease in Nigeria.

Authors:  A A Famodu
Journal:  J Clin Pathol       Date:  1987-12       Impact factor: 3.411

4.  Platelet hyperactivity in sickle-cell disease: a consequence of hyposplenism.

Authors:  M W Kenny; A J George; J Stuart
Journal:  J Clin Pathol       Date:  1980-07       Impact factor: 3.411

Review 5.  Interplay between coagulation and vascular inflammation in sickle cell disease.

Authors:  Erica Sparkenbaugh; Rafal Pawlinski
Journal:  Br J Haematol       Date:  2013-04-18       Impact factor: 6.998

Review 6.  How I diagnose and treat venous thromboembolism in sickle cell disease.

Authors:  Arun S Shet; Ted Wun
Journal:  Blood       Date:  2018-05-15       Impact factor: 22.113

Review 7.  Coagulation abnormalities of sickle cell disease: Relationship with clinical outcomes and the effect of disease modifying therapies.

Authors:  Denis Noubouossie; Nigel S Key; Kenneth I Ataga
Journal:  Blood Rev       Date:  2015-12-24       Impact factor: 8.250

8.  Coagulation activation in children with sickle cell disease is associated with cerebral small vessel vasculopathy.

Authors:  Raffaella Colombatti; Emiliano De Bon; Antonella Bertomoro; Alessandra Casonato; Elena Pontara; Elisabetta Omenetto; Graziella Saggiorato; Agostino Steffan; Tamara Damian; Giuseppe Cella; Simone Teso; Renzo Manara; Patrizia Rampazzo; Giorgio Meneghetti; Giuseppe Basso; Maria Teresa Sartori; Laura Sainati
Journal:  PLoS One       Date:  2013-10-25       Impact factor: 3.240

9.  Successful pulmonary thromboendarterectomy in a patient with sickle cell disease and associated resolution of a leg ulcer.

Authors:  Abhinav Agrawal; Rakesh Shah; Matthew D Bacchetta; Arunabh Talwar
Journal:  Lung India       Date:  2018 Jan-Feb

10.  The molecular basis for the prothrombotic state in sickle cell disease.

Authors:  Arun S Shet; Maria A Lizarralde-Iragorri; Rakhi P Naik
Journal:  Haematologica       Date:  2020-10-01       Impact factor: 9.941

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.